A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
2. van der Bruggen P, Traversari C, Chomez P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991: 254: 1643-7.
Structure, chromosomal localization, and expression of 12 genes of the MAGE family
3. De Plaen E, Arden K, Traversari C et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994: 40: 360-9.
Two members of the human MAGE B gene family located in Xp21.3 are expressed in tumors of various histological origins
4. Lurquin C, De Smet C, Brasseur F et al. Two members of the human MAGE B gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics 1997: 46: 397-408.
Identification of a new MAGE gene with tumor-specific expression by representational difference analysis
5. Lucas S, De Smet C, Arden KC et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 1998: 58: 743-52.
Structure, chromosomal location, and expression pattern of three mouse genes homologous to the human MAGE genes
6. De Backer O, Verheyden AM, Martin B et al. Structure, chromosomal location, and expression pattern of three mouse genes homologous to the human MAGE genes. Genomics 1995: 28: 74-83.
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E
8. Traversari C, van der Bruggen P, Luescher IF et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992: 176: 1453-7.
Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1
9. Chaux P, Luiten R, Demotte N et al. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. J Immunol 1999: 163: 2928-36.
Generation of specific antitumor reactivity by the stimulation of spleen cells from gastric cancer patients with MAGE-3 synthetic peptide
11. Fujie T, Tanaka F, Tahara K et al. Generation of specific antitumor reactivity by the stimulation of spleen cells from gastric cancer patients with MAGE-3 synthetic peptide. Cancer Immunol Immunother 1999: 48: 189-94.
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
12. Marchand M, van Baren N, Weynants P et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 1999: 80: 219-30.
Naturally occurring cancer in pet dogs: Important models for developing improved cancer therapy for humans
13. Knapp DW, Waters DJ. Naturally occurring cancer in pet dogs: important models for developing improved cancer therapy for humans. Mol Med Today 1997: 3: 8-11.